ArticleMedicine2020

A rare double ALK fusion variant EML4-ALK and CDK15-ALK in lung adenocarcinoma and response to crizotinib: A case report.

Jun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.